TRAF6 inhibits proangiogenic signals in endothelial cells and regulates the expression of vascular endothelial growth factor

Biochemical and Biophysical Research Communications

Volumn 419, Issue 1, 2012, Pages 66-71

  Bruneau, Sarah ^a,b   Datta, Dipak ^a,b   Flaxenburg, Jesse A ^a,b   Pal, Soumitro ^a,b   Briscoe, David M ^a,b  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Angiogenesis; Endothelial cell; Inflammation; Signal transduction; VEGF

Indexed keywords

PROTEIN TYROSINE KINASE; SARACATINIB; SMALL INTERFERING RNA; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 1; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 2; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 3; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 5; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 6; VASCULOTROPIN;

ANGIOGENESIS; ARTICLE; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVATION; HUMAN; HUMAN CELL; IN VITRO STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; UMBILICAL VEIN ENDOTHELIAL CELL; WOUND HEALING;

BENZODIOXOLES; CELL MOVEMENT; CELL PROLIFERATION; GENE KNOCKDOWN TECHNIQUES; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; LUCIFERASES; NEOVASCULARIZATION, PHYSIOLOGIC; PROMOTER REGIONS, GENETIC; QUINAZOLINES; RNA, SMALL INTERFERING; SRC-FAMILY KINASES; TNF RECEPTOR-ASSOCIATED FACTOR 6; TRANSCRIPTIONAL ACTIVATION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84857654448     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2012.01.128     Document Type: Article

References (40)

1. Cotran R. Inflammation and repair. Pathologic Basis of Disease 1994, 51-92. W. B. Saunders, Philadelphia. J.R.S. Cotran, V. Kumar, S.L. Robbins (Eds.).
2. Melter M., Reinders M.E., Sho M., et al. Ligation of CD40 induces the expression of vascular endothelial growth factor by endothelial cells and monocytes and promotes angiogenesis in vivo. Blood 2000, 96:3801-3808.
3. Reinders M.E., Sho M., Robertson S.W., et al. Proangiogenic function of CD40 ligand-CD40 interactions. J. Immunol. 2003, 171:1534-1541.
4. Chiodoni C., Iezzi M., Guiducci C., et al. Triggering CD40 on endothelial cells contributes to tumor growth. J. Exp. Med. 2006, 203:2441-2450.
5. Bergmann S., Pandolfi P.P. Giving blood: a new role for CD40 in tumorigenesis. J. Exp. Med. 2006, 203:2409-2412.
6. Yoshida S., Ono M., Shono T., et al. Involvement of interleukin-8, vascular endothelial growth factor, and basic fibroblast growth factor in tumor necrosis factor alpha-dependent angiogenesis. Mol. Cell Biol. 1997, 17:4015-4023.
7. Bottomley M.J., Webb N.J., Watson C.J., et al. Peripheral blood mononuclear cells from patients with rheumatoid arthritis spontaneously secrete vascular endothelial growth factor (VEGF): specific up-regulation by tumour necrosis factor-alpha (TNF-alpha) in synovial fluid. Clin. Exp. Immunol. 1999, 117:171-176.
8. Dormond O., Contreras A.G., Meijer E., et al. CD40-induced signaling in human endothelial cells results in mTORC2- and Akt-dependent expression of vascular endothelial growth factor in vitro and in vivo. J. Immunol. 2008, 181:8088-8095.
9. Pullen S.S., Miller H.G., Everdeen D.S., et al. CD40-tumor necrosis factor receptor-associated factor (TRAF) interactions: regulation of CD40 signaling through multiple TRAF binding sites and TRAF hetero-oligomerization. Biochemistry 1998, 37:11836-11845.
10. Hu H.M., O'Rourke K., Boguski M.S., et al. A novel RING finger protein interacts with the cytoplasmic domain of CD40. J. Biol. Chem. 1994, 269:30069-30072.
11. Ishida T., Mizushima S., Azuma S., et al. Identification of TRAF6, a novel tumor necrosis factor receptor-associated factor protein that mediates signaling from an amino-terminal domain of the CD40 cytoplasmic region. J. Biol. Chem. 1996, 271:28745-28748.
12. Ishida T.K., Tojo T., Aoki T., et al. TRAF5, a novel tumor necrosis factor receptor-associated factor family protein, mediates CD40 signaling. Proc. Natl. Acad. Sci. USA 1996, 93:9437-9442.
13. Tsitsikov E.N., Laouini D., Dunn I.F., et al. TRAF1 is a negative regulator of TNF signaling. enhanced TNF signaling in TRAF1-deficient mice. Immunity 2001, 15:647-657.
14. Arch R.H., Gedrich R.W., Thompson C.B. Tumor necrosis factor receptor-associated factors (TRAFs)-a family of adapter proteins that regulates life and death. Genes Dev. 1998, 12:2821-2830.
15. Bradley J.R., Pober J.S. Tumor necrosis factor receptor-associated factors (TRAFs). Oncogene 2001, 20:6482-6491.
16. Hsu H., Shu H.B., Pan M.G., et al. TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor 1 signal transduction pathways. Cell 1996, 84:299-308.
17. Rothe M., Wong S.C., Henzel W.J., et al. A novel family of putative signal transducers associated with the cytoplasmic domain of the 75 kDa tumor necrosis factor receptor. Cell 1994, 78:681-692.
18. Baud V., Karin M. Signal transduction by tumor necrosis factor and its relatives. Trends Cell Biol. 2001, 11:372-377.
19. Arron J.R., Pewzner-Jung Y., Walsh M.C., et al. Regulation of the subcellular localization of tumor necrosis factor receptor-associated factor (TRAF)2 by TRAF1 reveals mechanisms of TRAF2 signaling. J. Exp. Med. 2002, 196:923-934.
20. Krajewska M., Krajewski S., Zapata J.M., et al. TRAF-4 expression in epithelial progenitor cells analysis in normal adult, fetal, and tumor tissues. Am. J. Pathol. 1998, 152:1549-1561.
21. Flaxenburg J.A., Melter M., Lapchak P.H., et al. The CD40-induced signaling pathway in endothelial cells resulting in the overexpression of vascular endothelial growth factor involves Ras and phosphatidylinositol 3-kinase. J. Immunol. 2004, 172:7503-7509.
22. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-delta delta C(T)) method. Methods 2001, 25:402-408.
23. Zirlik A., Bavendiek U., Libby P., et al. TRAF-1, -2, -3, -5, and -6 are induced in atherosclerotic plaques and differentially mediate proinflammatory functions of CD40L in endothelial cells. Arterioscler. Thromb. Vasc. Biol. 2007, 27:1101-1107.
24. Lapchak P.H., Melter M., Pal S., et al. CD40-induced transcriptional activation of vascular endothelial growth factor involves a 68-bp region of the promoter containing a CpG island. Am. J. Physiol. Renal Physiol. 2004, 287:F512-F520.
25. X. Zhang, E. Rozengurt, E.F. Reed, HLA class I molecules partner with integrin beta4 to stimulate endothelial cell proliferation and migration, Sci. Signal. 3 ra85.
26. Schonbeck U., Libby P. The CD40/CD154 receptor/ligand dyad. Cell Mol. Life Sci. 2001, 58:4-43.
27. Bishop G.A., Hostager B.S. The CD40-CD154 interaction in B cell-T cell liaisons. Cytokine Growth Factor Rev. 2003, 14:297-309.
28. M.M. Harnett, CD40: a growing cytoplasmic tale, Sci. STKE. 2004 (2004) pe25.
29. Kehry M.R. CD40-mediated signaling in B cells. Balancing cell survival, growth, and death,. J. Immunol. 1996, 156:2345-2348.
30. Min W., Pober J.S. TNF initiates E-selectin transcription in human endothelial cells through parallel TRAF-NF-kappa B and TRAF-RAC/CDC42-JNK-c-Jun/ATF2 pathways. J. Immunol. 1997, 159:3508-3518.
31. Feng X., Gaeta M.L., Madge L.A., et al. Caveolin-1 associates with TRAF2 to form a complex that is recruited to tumor necrosis factor receptors. J. Biol. Chem. 2001, 276:8341-8349.
32. Urbich C., Mallat Z., Tedgui A., et al. Upregulation of TRAF-3 by shear stress blocks CD40-mediated endothelial activation. J. Clin. Invest. 2001, 108:1451-1458.
33. Frater-Schroder M., Risau W., Hallmann R., et al. Tumor necrosis factor type alpha, a potent inhibitor of endothelial cell growth in vitro, is angiogenic in vivo. Proc. Natl. Acad. Sci. USA 1987, 84:5277-5281.
34. Leibovich S.J., Polverini P.J., Shepard H.M., et al. Macrophage-induced angiogenesis is mediated by tumour necrosis factor-alpha. Nature 1987, 329:630-632.
35. Fajardo L.F., Kwan H.H., Kowalski J., et al. Dual role of tumor necrosis factor-alpha in angiogenesis. Am. J. Pathol. 1992, 140:539-544.
36. Park S.I., Shah A.N., Zhang J., et al. Regulation of angiogenesis and vascular permeability by Src family kinases: opportunities for therapeutic treatment of solid tumors. Expert Opin. Ther. Targets. 2007, 11:1207-1217.
37. Hoefen R.J., Berk B.C. The role of MAP kinases in endothelial activation. Vascul. Pharmacol. 2002, 38:271-273.
38. Brown L.F., Detmar M., Claffey K., et al. Vascular permeability factor/vascular endothelial growth factor: a multifunctional angiogenic cytokine. EXS. 1997, 79:233-269.
39. Moulton K.S., Heller E., Konerding M.A., et al. Angiogenesis inhibitors endostatin or TNP-470 reduce intimal neovascularization and plaque growth in apolipoprotein E-deficient mice. Circulation 1999, 99:1726-1732.
40. Moulton K.S., Vakili K., Zurakowski D., et al. Inhibition of plaque neovascularization reduces macrophage accumulation and progression of advanced atherosclerosis. Proc. Natl. Acad. Sci. USA 2003, 100:4736-4741.